N-Methylglucamine antimonate, a prevalent biomedical product, has found extensive application in combatting leishmaniasis, an affliction generated by Leishmania species. By restraining the proliferation and replication of the parasite, this compound offers respite from the distressing manifestations associated with this incapacitating ailment. Intravenous as well as intramuscular administration routes can be utilized for the delivery of N-Methylglucamine antimonate, elucidating its versatility in therapeutic intervention.